4.5 Article

Neurocognitive Functioning in Patients With Bipolar I Disorder Recently Recovered From a First Manic Episode

期刊

JOURNAL OF CLINICAL PSYCHIATRY
卷 71, 期 9, 页码 1234-1242

出版社

PHYSICIANS POSTGRADUATE PRESS
DOI: 10.4088/JCP.08m04997yel

关键词

-

资金

  1. The National Council for Scientific and Technological Development
  2. National Alliance for Research on Schizophrenia and Depression
  3. Stanley Medical Research Institute
  4. Eli Lilly
  5. AstraZeneca
  6. Sanofi-Aventis
  7. GlaxoSmithKline
  8. Servier
  9. Canadian Institutes of Health Research
  10. Advanced Neuromodulation Systems Inc
  11. BrainCells Inc
  12. Biovail
  13. Canadian Network for Mood and Anxiety Treatments
  14. Janssen
  15. Litebook Company Ltd
  16. Lundbeck
  17. Vancouver General Hospital
  18. UBC Hospital Foundation
  19. Common Drug Review
  20. Takeda
  21. Canadian Psychiatric Research Foundation
  22. Mathematics of Information Technology and Advanced Computing Systems
  23. Michael Smith Foundation for Health Research
  24. UBC Institute of Mental Health/Coast Capital Savings
  25. Bristol-Myers Squibb
  26. Novartis
  27. Pfizer
  28. AstraZeneca Canada

向作者/读者索取更多资源

Objective: Although cognitive impairment is an important clinical feature of bipolar disorder, it is unknown whether deficits are present at illness onset. The purpose of this study was to determine whether neuropsychological impairments are present in clinically stable patients with bipolar disorder shortly after resolution of their first manic episode. Method: Within a large university medical center, 45 recently diagnosed (DSM-IV-TR) patients with bipolar disorder type I were evaluated after resolution of their first manic episode, along with 25 matched healthy comparison subjects. Participants were administered a neuropsychological battery evaluating 5 broad cognitive domains, including verbal/premorbid intellectual functioning, learning/memory, spatial/nonverbal reasoning, attention/processing speed, and executive function. Data were collected from July 2004 to August 2007. Results: Relative to controls, patients showed broad impairments in learning/memory, spatial/nonverbal reasoning, executive function, and some aspects of attention (all P < .01). Specifically, deficits were evident on tests assessing sustained attention, attentional and mental set shifting, spatial working memory, nonverbal reasoning, and verbal learning and recall (all P < .01). Cognitive impairments in patients could not be fully attributed to substance abuse, medication status, or residual mood symptoms. Conclusions: Results indicate that core neuropsychological deficits in sustained attention, learning and recall, spatial/nonverbal reasoning, and several aspects of executive function are present at illness onset. Cognitive deficits in bipolar disorder are, thus, most likely not exclusively attributable to progressive decline associated with increased illness burden, cumulative treatment effects, or chronicity of illness. These findings may provide etiologic clues into the illness and identify clinical targets for early treatment. J Clin Psychiatry 2010;71(9):1234-1242 (C) Copyright 2010 Physicians Postgraduate Press, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据